Diabetes drug recalls
Every Class I, II, and III FDA recall affecting diabetes medications. Drugs in this category include Metformin, Insulin Glargine, Sitagliptin.
February 19, 20251 recall
October 9, 20241 recall
January 3, 20241 recall
July 12, 20231 recall
May 3, 20231 recall
March 29, 20231 recall
March 8, 20234 recalls
How FDA classifies recalls
Class I: The drug may cause serious health consequences or death. Examples include the wrong drug in a bottle, a drug contaminated with bacteria, or a life-threatening allergen not declared on the label.
Class II: The drug may cause temporary or medically reversible adverse health consequences, or the probability of serious consequences is remote. Examples include a dissolution failure, a labeling error that affects dosing, or a nitrosamine impurity above the daily intake limit.
Class III: Use of the drug is unlikely to cause adverse health consequences, but the product violates FDA regulations. Examples include an incorrect tablet count per bottle, minor labeling issues, or packaging defects.
Definitions sourced from FDA Recall Classifications →